Problem: The Indian pharma sector faces significant challenges with price erosion and high competition in the US generic drug market, despite an overall market growth. This puts pressure on revenues and profits. Solution: Implement flow management principles—control work-in-progress (WIP), ensure full kits of resources before starting projects, active task management, and project-level buffers. These practices prioritise critical tasks, reduce resource overload, and improve R&D efficiency. Benefits: The approach reduces lead times, enhances FDA submissions, boosts margins, and creates a more efficient and stress-free work environment, leading to greater capacity and profitability.

Key Takeaways

Generic drug development projects are often delayed. Simple execution process changes can help companies crash lead times in their filing process, increase FDA submissions and earn higher margins from their products.

Generic drug development: The prescription for success

Problem: The Indian pharmaceutical sector faces significant challenges with price erosion and high competition in the US generics drug market, despite overall market growth. This puts pressure on revenues and profits. Solution: Implement Flow management principles—control work-in-progress (WIP), ensure full kits of resources before starting projects, active task management, and project-level buffers. These practices prioritise critical tasks, reduce resource overload, and improve Research & Developemnt (R&D) efficiency. Benefits: The approach reduces lead times, enhances Food & Drug Administration (FDA ) submissions, boosts margins, and creates a more efficient and stress-free work environment, leading to greater capacity and profitability.

<h5>Generic drug development: The prescription for success</h5>

Download PDF

Vector Consulting Group - Research and Publications: Lead time reduction in R&amp;D can improve USFDA submission rates for generic pharma companies. Know more.